Seres Therapeutics, Inc.

Seres Therapeutics, Inc.

Seres Therapeutics, Inc.

Overview
Date Founded

2010

Headquarters

200 Sidney Street,4th Floor,Cambridge, MA 02139

Type of Company

Public

Employees (Worldwide)

108

Industries

Biotechnology
Pharmaceuticals
Hospitals & Patient Services
Holding Companies
Medical Support Services

Company Description

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Contact Data
Trying to get in touch with decision makers at Seres Therapeutics, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Executive Vice President, Chief Technology Officer

Executive Vice President, Chief Scientific Officer

Executive Vice President, Chief Legal Officer & Secretary

Executive Vice President, Chief People Officer

Chief Medical Officer & Executive Vice President

Head-Investor Relations

Benefit Plan Administrator

Executive Vice President, Chief Commercial & Strategy Officer

Senior Vice President, Principal Financial Officer

Board of Directors

Managing Partner at Flagship Pioneering

Former Chief Financial Officer & Executive Vice President at Novartis Corporation

Physician in Chief Emeritus of Medicine at The Massachusetts General Hospital

Professor & Executive Director-Personalized Health at University of Utah Health Sciences Center

Chairman, President & Chief Executive Officer at Intarcia Therapeutics, Inc.

President & Chief Executive Officer at Seres Therapeutics, Inc.

Executive Partner at Flagship Pioneering

Chief Executive Officer at Nestlé Health Science SA

Former Senior Vice President-Business Development & Corporate Licensing at Merck & Co., Inc.

Executive Vice President, Chief Legal Officer & Secretary at Seres Therapeutics, Inc.

Paths to Seres Therapeutics, Inc.
Potential Connections via
Relationship Science
You
Seres Therapeutics, Inc.
Owners & Shareholders
Details Hidden

ARK Investment Management is a registered investment adviser and privately held investment firm, specializing in thematic investing. The firm is rooted in over thirty years of experience in identifying and investing in disruptive innovations that enable outsized growth as industries transform. Through its open source research process, ARK is able to identify companies that it believes are leading and benefiting from disruptive cross-sector forces and changing how the world works.

Details Hidden

Nikko AMA offers both active and passive investment capabilities across equity, fixed income and alternative asset classes, with key strengths in multiple-pan-Asian asset strategies. Equity analysts are assigned responsibilities based on geographic regions, sectors or investment styles. The firm’s general approach focuses on fundamental bottom-up analysis; although it will vary depending on specific requirements of the investment strategy pursued and is tailored accordingly. Nikko AMA also provides broad coverage of global fixed income markets and currencies with consideration to the following factors: Macro Fundamentals, Interest Rates, Market Liquidity, and Investor Positioning/Relative Performance.

Details Hidden

RA Capital Management, LLC (“RA Capital”) is a crossover fund manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. The flexibility of its strategy allows RA Capital to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with minimal capital concerns from inception through commercialization.

Recent Transactions
Details Hidden

Seres Therapeutics, Inc. issued USD Common Stock

Details Hidden

Seres Therapeutics, Inc. issued . USD Common Stock

Details Hidden

Seres Therapeutics, Inc. issued USD Common Stock

Insider Transactions
Details Hidden
Transaction Advisors
Auditor

Advised onSeres Therapeutics, Inc. issued USD Common Stock

Escrow Agent

Advised onSeres Therapeutics, Inc. issued USD Common Stock

Underwriter

Advised onSeres Therapeutics, Inc. issued USD Common Stock

Legal Advisor

Advised onSeres Therapeutics, Inc. issued USD Common Stock

Director, Initial Public Offerings

Advised onSeres Therapeutics, Inc. issued USD Common Stock

Legal Advisor

Advised onSeres Therapeutics, Inc. issued USD Common Stock

Advisors & Consultants
Advisor

Faculty Director of the Deshpande Center for Technological Innovation at Massachusetts Institute of Technology

Legal Advisor

Partner at Goodwin Procter LLP

Advisor

Scientific Co-Founder at Inari Agriculture, Inc.

Clients

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Nestlé S.A. is a Swiss multinational food and drink processing conglomerate corporation headquartered in Vevey, Vaud, Switzerland. It is the largest food company in the world, measured by revenues and other metrics, since 2014. It ranked No. 64 on the Fortune Global 500 in 2017 and No. 33 on the 2016 edition of the Forbes Global 2000 list of largest public companies. Nestlé's products include baby food, medical food, bottled water, breakfast cereals, coffee and tea, confectionery, dairy products, ice cream, frozen food, pet foods, and snacks. Twenty-nine of Nestlé's brands have annual sales of over CHF1 billion (about US$1.1 billion), including Nespresso, Nescafé, Kit Kat, Smarties, Nesquik, Stouffer's, Vittel, and Maggi. Nestlé has 447 factories, operates in 189 countries, and employs around 339,000 people. It is one of the main shareholders of L'Oreal, the world's largest cosmetics company. Nestlé was formed in 1905 by the merger of the Anglo-Swiss Milk Company, established in 1866 by brothers George and Charles Page, and Farine Lactée Henri Nestlé, founded in 1866 by Henri Nestlé. The company grew significantly during the First World War and again following the Second World War, expanding its offerings beyond its early condensed milk and infant formula products. The company has made a number of corporate acquisitions, including Crosse & Blackwell in 1950, Findus in 1963, Libby's in 1971, Rowntree Mackintosh in 1988, Klim in 1998, and Gerber in 2007. The company has seen various controversies, facing criticism and boycotts over its marketing of baby formula as an alternative to breastfeeding in developing countries, its reliance on child labour in cocoa production, and its production and promotion of bottled water.

Key Stats and Financials As of 2019
Market Capitalization
$2.52B
Total Enterprise Value
$145M
Earnings Per Share
$-1.24
Revenue
$34.5M
Net Profit
$-70.3M
EBITDA
$-60.6M
EBITDAMargin
-175.49%
Total Debt
$44.8M
Total Equity
$-48.3M
Enterprise Value / Sales
4.21x
TEVNet Income
-2.07x
Debt TEV
0.31x
Three Year Compounded Annual Growth Rate Of Revenue
16.6%
Investors
Details Hidden

4bio Capital Partners invest in companies located in UK. The firm targets the companies operating in the fields of gene therapy, cell theray, RNA based therapy, targeted therapies and microbiome. They provide financing for early stage capital requirements.

Details Hidden

President at Epiva Biosciences, Inc.

Details Hidden

Co-Founder at Moderna, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Seres Therapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Seres Therapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Seres Therapeutics, Inc..